Cargando…

Therapeutic potential of mesenchymal stromal cells for hypoxic ischemic encephalopathy: A systematic review and meta-analysis of preclinical studies

INTRODUCTION: Neonatal hypoxic ischemic encephalopathy (HIE) is a devastating neurologic condition with high mortality rates and long-term complications for surviving infants. Mesenchymal stem/stromal cells (MSCs) have emerged as novel therapeutic agents with promising results in experimental studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Archambault, Jamie, Moreira, Alvaro, McDaniel, Dawn, Winter, Lauryn, Sun, LuZhe, Hornsby, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736208/
https://www.ncbi.nlm.nih.gov/pubmed/29261798
http://dx.doi.org/10.1371/journal.pone.0189895
_version_ 1783287337625583616
author Archambault, Jamie
Moreira, Alvaro
McDaniel, Dawn
Winter, Lauryn
Sun, LuZhe
Hornsby, Peter
author_facet Archambault, Jamie
Moreira, Alvaro
McDaniel, Dawn
Winter, Lauryn
Sun, LuZhe
Hornsby, Peter
author_sort Archambault, Jamie
collection PubMed
description INTRODUCTION: Neonatal hypoxic ischemic encephalopathy (HIE) is a devastating neurologic condition with high mortality rates and long-term complications for surviving infants. Mesenchymal stem/stromal cells (MSCs) have emerged as novel therapeutic agents with promising results in experimental studies of HIE. The purpose of this study is to (a) methodically review the current preclinical literature describing MSC therapy in animal models of HIE, (b) quantify the effect size in regards to functional neurologic outcome, and (c) identify research gaps/limitations that should be addressed prior to future preclinical and clinical studies. METHODS: Adhering to the Systematic Review Protocol for Animal Intervention Studies, a systematic search of English articles was performed. Eligible studies were identified and data regarding study characteristics and outcome measures was extracted. After quality assessment, meta-analysis and meta-regression were performed to generate random effect size using standardized mean difference (SMD). Funnel plots and Egger’s tests were utilized to evaluate for the presence of publication bias. RESULTS: A total of 19 studies met inclusion in the current systematic review. Meta-analysis revealed that MSCs have a significant positive effect on neurobehavioral outcome following HIE injury. Sensorimotor function was improved by 2.25 SMD (95% CI; 2.04–2.46) in cylinder rearing and 2.97 SMD (95% CI; 2.56–3.38) in rotarod. Likewise, cognitive function was improved by 2.76 SMD (95% CI; 2.53–2.98) on the water maze and 2.97 SMD (95% CI; 2.58–3.35) in object recognition. Stratification demonstrated an increased effect size depending on various study characteristics. CONCLUSIONS: Overall, these results suggest a promising role for MSCs in preclinical studies of HIE. MSC treatment demonstrates improved functional outcomes that are encouraging for future translational studies. While risk of bias and heterogeneity limited the strength of our meta-analysis, our results are consistent with those seen in this field of research.
format Online
Article
Text
id pubmed-5736208
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-57362082017-12-22 Therapeutic potential of mesenchymal stromal cells for hypoxic ischemic encephalopathy: A systematic review and meta-analysis of preclinical studies Archambault, Jamie Moreira, Alvaro McDaniel, Dawn Winter, Lauryn Sun, LuZhe Hornsby, Peter PLoS One Research Article INTRODUCTION: Neonatal hypoxic ischemic encephalopathy (HIE) is a devastating neurologic condition with high mortality rates and long-term complications for surviving infants. Mesenchymal stem/stromal cells (MSCs) have emerged as novel therapeutic agents with promising results in experimental studies of HIE. The purpose of this study is to (a) methodically review the current preclinical literature describing MSC therapy in animal models of HIE, (b) quantify the effect size in regards to functional neurologic outcome, and (c) identify research gaps/limitations that should be addressed prior to future preclinical and clinical studies. METHODS: Adhering to the Systematic Review Protocol for Animal Intervention Studies, a systematic search of English articles was performed. Eligible studies were identified and data regarding study characteristics and outcome measures was extracted. After quality assessment, meta-analysis and meta-regression were performed to generate random effect size using standardized mean difference (SMD). Funnel plots and Egger’s tests were utilized to evaluate for the presence of publication bias. RESULTS: A total of 19 studies met inclusion in the current systematic review. Meta-analysis revealed that MSCs have a significant positive effect on neurobehavioral outcome following HIE injury. Sensorimotor function was improved by 2.25 SMD (95% CI; 2.04–2.46) in cylinder rearing and 2.97 SMD (95% CI; 2.56–3.38) in rotarod. Likewise, cognitive function was improved by 2.76 SMD (95% CI; 2.53–2.98) on the water maze and 2.97 SMD (95% CI; 2.58–3.35) in object recognition. Stratification demonstrated an increased effect size depending on various study characteristics. CONCLUSIONS: Overall, these results suggest a promising role for MSCs in preclinical studies of HIE. MSC treatment demonstrates improved functional outcomes that are encouraging for future translational studies. While risk of bias and heterogeneity limited the strength of our meta-analysis, our results are consistent with those seen in this field of research. Public Library of Science 2017-12-19 /pmc/articles/PMC5736208/ /pubmed/29261798 http://dx.doi.org/10.1371/journal.pone.0189895 Text en © 2017 Archambault et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Archambault, Jamie
Moreira, Alvaro
McDaniel, Dawn
Winter, Lauryn
Sun, LuZhe
Hornsby, Peter
Therapeutic potential of mesenchymal stromal cells for hypoxic ischemic encephalopathy: A systematic review and meta-analysis of preclinical studies
title Therapeutic potential of mesenchymal stromal cells for hypoxic ischemic encephalopathy: A systematic review and meta-analysis of preclinical studies
title_full Therapeutic potential of mesenchymal stromal cells for hypoxic ischemic encephalopathy: A systematic review and meta-analysis of preclinical studies
title_fullStr Therapeutic potential of mesenchymal stromal cells for hypoxic ischemic encephalopathy: A systematic review and meta-analysis of preclinical studies
title_full_unstemmed Therapeutic potential of mesenchymal stromal cells for hypoxic ischemic encephalopathy: A systematic review and meta-analysis of preclinical studies
title_short Therapeutic potential of mesenchymal stromal cells for hypoxic ischemic encephalopathy: A systematic review and meta-analysis of preclinical studies
title_sort therapeutic potential of mesenchymal stromal cells for hypoxic ischemic encephalopathy: a systematic review and meta-analysis of preclinical studies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736208/
https://www.ncbi.nlm.nih.gov/pubmed/29261798
http://dx.doi.org/10.1371/journal.pone.0189895
work_keys_str_mv AT archambaultjamie therapeuticpotentialofmesenchymalstromalcellsforhypoxicischemicencephalopathyasystematicreviewandmetaanalysisofpreclinicalstudies
AT moreiraalvaro therapeuticpotentialofmesenchymalstromalcellsforhypoxicischemicencephalopathyasystematicreviewandmetaanalysisofpreclinicalstudies
AT mcdanieldawn therapeuticpotentialofmesenchymalstromalcellsforhypoxicischemicencephalopathyasystematicreviewandmetaanalysisofpreclinicalstudies
AT winterlauryn therapeuticpotentialofmesenchymalstromalcellsforhypoxicischemicencephalopathyasystematicreviewandmetaanalysisofpreclinicalstudies
AT sunluzhe therapeuticpotentialofmesenchymalstromalcellsforhypoxicischemicencephalopathyasystematicreviewandmetaanalysisofpreclinicalstudies
AT hornsbypeter therapeuticpotentialofmesenchymalstromalcellsforhypoxicischemicencephalopathyasystematicreviewandmetaanalysisofpreclinicalstudies